Capricor Therapeutics
CAPR
#7998
Rank
NZ$0.49 B
Marketcap
NZ$10.93
Share price
-4.36%
Change (1 day)
-57.34%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -NZ$0.15 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are NZ$11.13 Million. In 2024 the company made an earning of -NZ$69.57 Million a decrease over its 2023 earnings that were of -NZ$38.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.15 Billion102.04%
2024 -NZ$69.57 Million81.57%
2023 -NZ$38.32 Million-23.2%
2022 -NZ$49.89 Million44.93%
2021 -NZ$34.43 Million46.61%
2020 -NZ$23.48 Million78.71%
2019 -NZ$13.14 Million-49.7%
2018 -NZ$26.12 Million-724.78%
2017 NZ$4.17 M-112.93%
2016 -NZ$32.34 Million46.27%
2015 -NZ$22.11 Million106.82%
2014 -NZ$10.69 Million-48.41%
2013 -NZ$20.72 Million977.23%
2012 -NZ$1.93 Million-77.11%
2011 -NZ$8.41 Million-22.35%
2010 -NZ$10.82 Million-20.17%
2009 -NZ$13.56 Million-41.17%
2008 -NZ$23.04 Million41.05%
2007 -NZ$16.34 Million1098.87%
2006 -NZ$1.37 Million4101.55%
2005 -NZ$0.04 Million-0.97%
2004 -NZ$0.04 Million17.87%
2003 -NZ$0.03 Million3.66%
2002 -NZ$0.03 Million-30.11%
2001 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-NZ$1.3 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$29.73 Million-78.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.69 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.00 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.32 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA